IPLab:Lab 2:Atrophy

From Pathology Education Instructional Resource
Jump to navigation Jump to search

Clinical Summary

This 74-year-old man was found to have carcinoma of the prostate six years prior to his death. The serum prostate-specific antigen (PSA) level was 9.7 ng/ml. His plasma acid phosphatase level on repeated tests ranged from 2 to 4 IU/L. X-rays revealed metastatic lesions in the patient's pelvis and vertebral column. He refused to have an orchiectomy and was placed on estrogen therapy (diethylstilbestrol).

The patient's terminal admission was for renal failure. The tumor had grown into the floor of the urinary bladder causing obstruction of the ureters at their entrance to the bladder. The patient developed acute hydronephrosis which was drained by nephrostomies. Eventually, infection developed in the kidneys resulting in Gram-negative sepsis and death.

Images

Virtual Microscopy

Testis: Atrophy

<peir-vm>IPLab2Atrophy</peir-vm>

Normal Testis

<peir-vm>UAB-Histology-00045</peir-vm>

Study Questions

  • <spoiler text="What is PSA and how useful is it as a marker of prostatic cancer?">Prostatic Specific Antigen. PSA can be a useful marker for prostatic cancer; however, PSA levels may be elevated for a number of reasons other than cancer.</spoiler>
  • <spoiler text="What is the cause of testicular atrophy in this case?">The cause was HORMONAL.

Prostatic growth is dependent upon testicular androgens. Estrogen therapy leads to inhibition of pituitary gonadotropin and/or ACTH production which causes androgen deprivation. Newer drugs use specific testosterone receptor blocking mechanisms to regress prostate hyperplasia and prostate cancer.</spoiler>

  • <spoiler text="There appears to be an increase in the number of interstitial cells. Is there such a thing as Leydig cell hyperplasia?">No. The Leydig cells appear more prominent due to the paucity of germ cells.</spoiler>

Additional Resources

Reference

Journal Articles

Images